Mediolanum International Funds Ltd

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2022028 DUBLIN 1, L2

Position in VRTX

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$2,869,112

+$321,602 QoQ

Shares Held

5,776

+1.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#591

of 1,735 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mediolanum International Funds Ltd holds $75,305,474 across 10 Biotechnology names. VRTX ranks #7 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	29,785	$27,633,629
2	ALNY	Alnylam Pharmaceuticals, Inc.	46,396	$13,966,587
3	REGN	Regeneron Pharmaceuticals, Inc.	14,754	$9,199,709
4	INCY	Incyte Corp	76,627	$8,686,436
5	KRYS	Krystal Biotech, Inc.	15,940	$5,924,419
6	ASND	Ascendis Pharma A/S	11,697	$3,119,823
7	VRTX	Vertex Pharmaceuticals Inc / Ma This page	5,776	$2,869,112
8	ARWR	Arrowhead Pharmaceuticals, Inc.	28,940	$2,358,899

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,869,112	5,776	+1.2%	Shares	Sole	2026-07-23
2026-03-31	$2,547,510	5,705	+4.0%	Shares	Sole	2026-05-06
2025-12-31	$2,487,586	5,487	-35.8%	Shares	Sole	2026-02-09
2025-09-30	$3,346,172	8,544	+55.5%	Shares	Sole	2025-11-04
2025-06-30	$2,445,928	5,494	+1.2%	Shares	Sole	2025-08-12
2025-03-31	$2,631,602	5,428	-4.8%	Shares	Sole	2025-05-07
2024-12-31	$2,295,792	5,701	+7.6%	Shares	Sole	2025-01-23
2024-09-30	$2,464,458	5,299	-85.8%	Shares	Sole	2024-10-23
2024-06-30	$17,532,002	37,404	+1.1%	Shares	Sole	2024-08-13
2024-03-31	$15,467,206	37,002	—	Shares	Sole	2024-05-03
No filing history on record for this holder in this stock.